Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it's final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.
Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it's final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.
Air shipping is set to dominate the biopharmaceutical logistics market. The expansion of the air shipping segment is attributed to air freight being the fastest way of transporting pharmaceutical products with negligible damage or product deterioration, which is desired for transporting temperature-sensitive vaccines and critical biologic drugs. However, air shipping has a limitation of volume which can be transferred, so sea shipping and ground shipping will outpace air shipping in volume growth during the forecast period.
Market competition is intense. Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken), DB Schenker etc. are the leaders of the industry, and they hold key technologies, with high-end customers: have been formed in the monopoly position in the industry.
According to this study, over the next five years the Biopharmaceutical Logistic market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 89900 million by 2024, from US$ 71000 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biopharmaceutical Logistic business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Logistic market by product type, application, key manufacturers and key regions and countries.
This study considers the Biopharmaceutical Logistic value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Cold Chain Logistics
Non-cold Chain Logistics
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
Ground Shipping
Sea Shipping
Air Shipping
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Deutsche Post DHL
Kuehne + Nagel
FedEx
AmerisourceBergen
UPS (Marken)
DB Schenker
XPO Logistics
Panalpina
Nippon Express
GEODIS
VersaCold
Agility
DSV
Sinotrans
Kerry Logistics
SF Express
CEVA
CH Robinson
Air Canada Cargo
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biopharmaceutical Logistic consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Biopharmaceutical Logistic market by identifying its various subsegments.
Focuses on the key global Biopharmaceutical Logistic manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biopharmaceutical Logistic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biopharmaceutical Logistic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
